|
|
Update: Evaluation of Airborne Chemicals from Neonatal Incubators – Letter to Health Care Providers
Today, the FDA provided an update on its evaluation of the potential for exposure to airborne chemicals that may be released from neonatal incubators.
Based on the FDA's review of the totality of the available information including testing data, we have determined that all new neonatal incubators currently supplied in the United States do not demonstrate concerning levels of airborne chemicals and therefore do not need to be run for a week before clinical use.
The Letter to Health Care Providers includes important information about neonatal incubators, including:
- Recommendations for health care providers.
- Actions that the FDA has taken to evaluate the potential for exposure to airborne chemicals that may be released from neonatal incubators.
- Instructions for reporting problems with a device.
Questions?
If you have questions about neonatal incubators, contact the Division of Industry and Consumer Education (DICE).
|
|
|
|
